跳至主要内容
临床试验/NCT01379677
NCT01379677已完成3 期

Diagnosis of Coronary Artery Disease With Rubidium-82 PET and Technetium-99m-MIBI SPET: A Head to Head Comparison, Versus Coronary CT Angiography

Advanced Accelerator Applications1 个研究点 分布在 1 个国家目标入组 135 人开始时间: 2011年2月最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
135
试验地点
1
主要终点
The specificity of detecting significant coronary artery disease (as defined as being >70% stenosis, on coronary CT angiography)

研究概览

简要总结

The main purpose of this study is to compare myocardial perfusion imaging using Rubidium-82 PET with Tc-99m-MIBI SPET, in the evaluation of significant Coronary Artery Disease (CAD).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Referred for scintigraphy to assess myocardial ischaemia
  • Ability to give informed written consent.

排除标准

  • Impaired capacity to consent
  • Pregnancy, or breastfeeding
  • Allergy to iv contrast
  • Renal failure
  • Severe Uncontrolled asthma
  • Claustrophobia

研究组 & 干预措施

Single arm

Other

This is an Head to Head Comparison between Rubidium-82 PET and Tc-99m-MIBI SPET with CTA as gold standard. All the patients will undergo the three imaging protocols.

干预措施: Rubidium-82 (Drug)

Single arm

Other

This is an Head to Head Comparison between Rubidium-82 PET and Tc-99m-MIBI SPET with CTA as gold standard. All the patients will undergo the three imaging protocols.

干预措施: Sestamibi. reconstitution with sodium pertechnetate (99mTc) (Drug)

结局指标

主要结局

The specificity of detecting significant coronary artery disease (as defined as being >70% stenosis, on coronary CT angiography)

时间窗: Up to 2 days

The primary objective is to compare PET vs. SPET, with the primary outcome being the specificity of detecting significant coronary artery disease (as defined as being \>70% stenosis, on coronary CT angiography).

次要结局

  • Evaluate any adverse events or reactions, during Rubidum-82 or Tc-MIBI administration.(Up to 2 days)
  • Evaluate any difference in the clinical interpretation of the Rubidium-82 PET and Tc-99m-MIBI SPET images.(Up to 2 days)
  • Evaluate any difference in "Percentage myocardium" that is hypoperfused, between Rubidium-82 PET and Tc-99m-MIBI SPET.(Up to 2 days)
  • Evaluate any difference in image quality, artefacts and interpretative confidence between Rubidium-82 PET and Tc-99m-MIBI SPET.(Up to 2 days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验